163 related articles for article (PubMed ID: 8173928)
1. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
[TBL] [Abstract][Full Text] [Related]
2. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
[TBL] [Abstract][Full Text] [Related]
3. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
Robinson MH; Marks CG; Farrands PA; Bostock K; Hardcastle JD
Br J Surg; 1996 Apr; 83(4):500-1. PubMed ID: 8665240
[TBL] [Abstract][Full Text] [Related]
4. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
Thomas WM; Pye G; Hardcastle JD; Mangham CM
Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
[TBL] [Abstract][Full Text] [Related]
5. Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study.
Robinson MH; Marks CG; Farrands PA; Whynes DK; Bostock K; Hardcastle JD
Eur J Surg Oncol; 1995 Jun; 21(3):261-4. PubMed ID: 7781793
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
[TBL] [Abstract][Full Text] [Related]
7. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients.
Thomas WM; Hardcastle JD; Jackson J; Pye G
Br J Cancer; 1992 Apr; 65(4):618-20. PubMed ID: 1562472
[TBL] [Abstract][Full Text] [Related]
8. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK
Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158
[TBL] [Abstract][Full Text] [Related]
9. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
Hunt LM; Rooney PS; Bostock K; Robinson MH; Hardcastle JD; Armitage NC
Gut; 1997 Jan; 40(1):110-2. PubMed ID: 9155586
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program.
Petrelli N; Michalek AM; Freedman A; Baroni M; Mink I; Rodriguez-Bigas M
Surg Oncol; 1994 Feb; 3(1):27-36. PubMed ID: 8186868
[TBL] [Abstract][Full Text] [Related]
11. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
12. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
Rozen P; Knaani J; Samuel Z
Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
[TBL] [Abstract][Full Text] [Related]
13. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
[TBL] [Abstract][Full Text] [Related]
14. Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population.
Caffarey SM; Broughton CI; Marks CG
Br J Surg; 1993 Nov; 80(11):1399-400. PubMed ID: 8252347
[TBL] [Abstract][Full Text] [Related]
15. Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms.
Silman AJ; Mitchell P; Nicholls RJ; Macrae FA; Leicester RJ; Bartram CI; Simmons MJ; Campbell PD; Hearn CE; Constable PJ
Br J Surg; 1983 Dec; 70(12):721-4. PubMed ID: 6605779
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of new occult blood tests for detection of colorectal neoplasia.
St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
[TBL] [Abstract][Full Text] [Related]
17. Haemoccult test properties according to type and number of positive slides in mass screening for colorectal cancer.
Launoy G; Herbert C; Reaud JM; Thezee Y; Tichet J; Maurel J; Ollivier V; Pegulu L; Caces E; Valla A
Br J Cancer; 1995 Oct; 72(4):1043-6. PubMed ID: 7547220
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions.
Castiglione G; Sala P; Ciatto S; Grazzini G; Mazzotta A; Rossetti C; Spinelli P; Bertario L
Eur J Cancer Prev; 1994 Sep; 3(5):399-405. PubMed ID: 8000308
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia.
Rozen P; Knaani J; Papo N
Eur J Cancer Prev; 1995 Dec; 4(6):475-81. PubMed ID: 8580783
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]